Mark Groves-Gidney CEO Trapoil (LON:TRAP) explains to Proactiveinvestors how the business model works and he lays out the investment case for the proposition. Mark highlights the "exciting" portfolio of exploration, appraisal and production assets centered on the UK North Sea comprising 20 licences and 46 blocks and part blocks. Mark also explains that at £30mln market cap the current share price pretty much represents the cash the company has and there's none of the exploration potential included.
Meet Tissue Regenix, ServicePower Technologies, Tekcapital and Ergomed at our event, London, 17 September 2015. Register here »